Patient Selection and Evidence for Intervention in Deep Vein Thrombosis and Pulmonary Embolism
- 1Department of General and Vascular Surgery, University Clinical Hospital in Poznan, Poznan University of Medical Sciences, ul. Długa 1/2, 61-848 Poznan, Poland
Abstract
Intervention for deep vein thrombosis (DVT) and pulmonary embolism (PE) should address a clinical problem that anticoagulation alone may not resolve. This narrative review separates whether to intervene, which procedure to choose, and how to maintain benefit. The review covers publications through 10 September 2026, with a later STORM-PE follow-up report identified separately. Anticoagulation remains foundational. In acute iliofemoral DVT, selected patients may gain earlier symptom relief or less severe post-thrombotic disease, but trials do not support routine thrombus removal. In established post-thrombotic obstruction, C-TRACT showed better six-month clinical severity and quality of life with stenting and enhanced antithrombotic treatment, alongside more bleeding. In selected stable PE, HI-PEITHO reduced a seven-day clinical composite from 10.3% to 4.0%, mainly through fewer episodes of decompensation; a survival benefit remains unproven. Procedure comparisons and imaging trials answer narrower questions than benefit over medical care. Limb-threatening DVT and unstable PE require urgent rescue assessment. A five-scenario table and clinical examples connect this evidence to symptoms, anatomy, recovery goals, bleeding risk, and the feasibility of continuing treatment and follow-up.
Related
- Renal vein thrombosis with inferior vena cava extension and pulmonary embolism in a patient with acute pyelonephritis: a case report and updated literature review
- Genetic Associations with Pulmonary Embolism among Those with a Deep Vein Thrombosis: The INVENT Consortium
- Case Report: Pulmonary reperfusion injury with bilateral bronchial cast thrombosis after VA-ECMO-bridged catheter-based reperfusion for cardiac arrest caused by high-risk pulmonary embolism.
- JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis
- New era of pulmonary embolism: Precision, intervention, and innovation
BibTeX
@article{mackowski2026patient,
title = {{Patient Selection and Evidence for Intervention in Deep Vein Thrombosis and Pulmonary Embolism}},
author = {Cezary Maćkowski and Zbigniew Krasiński and Michał-Goran Stanišić and Łukasz Kruszyna and Szymon Salamaga},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15218212},
url = {https://www.mdpi.com/2077-0383/15/21/8212},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Patient Selection and Evidence for Intervention in Deep Vein Thrombosis and Pulmonary Embolism
AU - Cezary Maćkowski
AU - Zbigniew Krasiński
AU - Michał-Goran Stanišić
AU - Łukasz Kruszyna
AU - Szymon Salamaga
PY - 2026
DA - 2026/10/22
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218212
UR - https://www.mdpi.com/2077-0383/15/21/8212
AB - Intervention for deep vein thrombosis (DVT) and pulmonary embolism (PE) should address a clinical problem that anticoagulation alone may not resolve. This narrative review separates whether to intervene, which procedure to choose, and how to maintain benefit. The review covers publications through 10 September 2026, with a later STORM-PE follow-up report identified separately. Anticoagulation remains foundational. In acute iliofemoral DVT, selected patients may gain earlier symptom relief or less severe post-thrombotic disease, but trials do not support routine thrombus removal. In established post-thrombotic obstruction, C-TRACT showed better six-month clinical severity and quality of life with stenting and enhanced antithrombotic treatment, alongside more bleeding. In selected stable PE, HI-PEITHO reduced a seven-day clinical composite from 10.3% to 4.0%, mainly through fewer episodes of decompensation; a survival benefit remains unproven. Procedure comparisons and imaging trials answer narrower questions than benefit over medical care. Limb-threatening DVT and unstable PE require urgent rescue assessment. A five-scenario table and clinical examples connect this evidence to symptoms, anatomy, recovery goals, bleeding risk, and the feasibility of continuing treatment and follow-up.
SN - 2077-0383
ER -